Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis.
Dmitrij KravchenkoAlexander IsaakSebastian ZimmerCan ÖztürkNarine MesropyanLeon M BischoffMarilia VoigtDaniel GinzburgUlrike AttenbergerClaus C PieperDaniel KuettingJulian Alexander LuetkensPublished in: European heart journal. Cardiovascular Imaging (2024)
ECV differentiates cardiac amyloidosis from other causes of LVH. T2 mapping combined with LGE differentiates AL from ATTR amyloidosis with high accuracy on a patient level.